Press Release: Progeria Research Foundation : US FDA Authorizes Launch of Clinical Trial to Support New Treatment Development for Progeria

New Trial to Study Progerinin Treatment for Ultra-Rare ConditionBUSAN, KOREA; PEABODY, MA; and GERMANTOWN, MD / ACCESSWIRE / October 2, 2024 / The United States Food and Drug Administration (FDA) has...